Gold nanoparticles in combination with megavoltage radiation energy increased radiosensitization and apoptosis in colon cancer HT-29 cells

References

• Andreyev HJN. 2007. Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol (R Coll Radiol). 19:790–799.
   PubMed Web of Science ®Google Scholar
• Arab-Bafrani Z, Shahbazi-Gahrouei D, Abbasian M, Fesharaki M. 2016. Multiple MTS assay as the alternative method to determine survival fraction of the irradiated HT-29 colon cancer cells. J Med Signals Sens. 6:112–116.
   PubMedGoogle Scholar
• Bian X, Liu B, Yang Y. 2016. Pathological complete response following neoadjuvant radiotherapy and intraperitoneal perfusion chemotherapy for recurrent colon carcinoma: a case report and literature review. Oncol Lett. 11:2747–2750.
   PubMed Web of Science ®Google Scholar
• Buch K, Peters T, Nawroth T, Sanger M, Schmidberger H, Langguth P. 2012. Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay – a comparative study. Radiat Oncol. 7:1.
   PubMed Web of Science ®Google Scholar
• Butterworth KT, Coulter JA, Jain S, Forker J, McMahon SJ, Schettino G. 2010. Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology. 21:1–18.
   Web of Science ®Google Scholar
• Cho SH. 2005. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Phys Med Biol. 50:163–173.
   PubMed Web of Science ®Google Scholar
• Cui X, Oonishi K, Tsujii H, Yasuda T, Matsumoto Y, Furusawa Y. 2011. Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. Cancer Res. 71:3676–3687.
   PubMed Web of Science ®Google Scholar
• Geng F, Song K, Xing JZ, Yuan C, Yan S, Yang Q, Chen J, Kong B. 2011. Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer. Nanotechnology. 22:285101.
   PubMed Web of Science ®Google Scholar
• Gu YJ, Cheng J, Lin CC, Lam YW, Cheng SH, Wong WT. 2009. Nuclear penetration of surface functionalized gold nanoparticles. Toxicol Appl Pharmacol. 2:196–204.
   Web of Science ®Google Scholar
• Jain S, Ch B, Coulter JA, Hounsell AR, Karl T. 2011. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Biol Phys. 79:531–539.
   PubMed Web of Science ®Google Scholar
• Jain S, Hirst DG, O’Sullivan JM. 2012. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol. 85:101–113.
   PubMed Web of Science ®Google Scholar
• Joh DY, Sun L, Stangl M, Al Zaki A, Murty S, Santoiemma PP, Davis JJ, Baumann BC, Alonso-Basanta M, Bhang D, et al. 2013. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS One. 8:e62425.
   PubMed Web of Science ®Google Scholar
• Kim HS, Lee MR. 2013. Diagnostic accuracy of elevated serum carcinoembryonic antigen for recurrence in postoperative stage II colorectal cancer patients: comparison with stage III. Ann Coloproctol. 29:155–159.
   PubMedGoogle Scholar
• Kong T, Zeng J, Wang X, Yang X, Yang J, McQuarrie S, McEwan A, Roa W, Chen J, Xing JZ. 2008. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small. 4:1537–1543.
   PubMed Web of Science ®Google Scholar
• Li X, Nie J, Mei Q, Han W-D. 2016. MicroRNAs: novel immunotherapeutic targets in colorectal carcinoma. World J Gastroenterol. 22:5317–5331.
   PubMed Web of Science ®Google Scholar
• McMahon SJ, Hyland WB, Muir MF, Coulter JA, Jain S, Butterworth KT. 2011a. Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy. Radiother Oncol. 100:412–416.
   PubMed Web of Science ®Google Scholar
• McMahon SJ, Hyland WB, Muir MF, Coulter JA, Jain S, Butterworth KT. 2011b. Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles. Sci Rep. 1:18.
   PubMed Web of Science ®Google Scholar
• McMahon SJ, Mendenhall MH, Jain S, Currell F. 2008. Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles. Phys Med Biol. 53:5635–5651.
   PubMed Web of Science ®Google Scholar
• Price P, McMillan TJ. 1990. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res. 50:1392–1396.
   PubMed Web of Science ®Google Scholar
• Pugh SA, Shinkins B, Fuller A, Mellor J, Mant D, Primrose JN. 2016. Site and stage of colorectal cancer influence the likelihood and distribution of disease recurrence and post recurrence survival: data from the FACS randomized controlled trial. Ann Surg. 263:1143–1147.
   PubMed Web of Science ®Google Scholar
• Rahman WN, Bishara N, Ackerly T, He CF, Jackson P, Wong C. 2009. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomed Nanotech Biol Med. 5:136–142.
   PubMed Web of Science ®Google Scholar
• Roa W, Zhang X, Guo L, Shaw A, Hu X, Xiong Y. 2009. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology. 20:375101.
   PubMed Web of Science ®Google Scholar
• Roy S, Majumdar AP. 2012. Signaling in colon cancer stem cells. J Mol Signal. 7:11.
   PubMedGoogle Scholar
• Ryuk JP, Choi G-S, Park JS, Kim HJ, Park SY, Yoon GS, Jun SH, Kwon YC. 2014. Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection. Ann Surg Treat Res. 86:143.
   PubMed Web of Science ®Google Scholar
• Seo YS, Kim M, Yoo H, Jang W. 2014. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer. World J Gastroenterol. 20:2005–2013.
   PubMed Web of Science ®Google Scholar
• Smith L, Kuncic Z, Ostrikov K, Kumar S. 2012. Nanoparticles in cancer imaging and therapy. J Nano Mat. 2012:1–7.
   Web of Science ®Google Scholar
• Song L, Falzone N, Vallis KA. 2016. EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer. Int J Radiat Biol. 21:18.
   Google Scholar
• Strunz AM, Peschke P, Waldeck W, Ehemann V, Kissel M, Debus J. 2002. Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control. Int J Radiat Biol. 78:721–732.
   PubMed Web of Science ®Google Scholar
• Sørensen CG, Karlsson WK, Pommergaard H-C, Burcharth J, Rosenberg J. 2016. The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence: a systematic review. Int J Surg. 25:134–144.
   PubMed Web of Science ®Google Scholar
• Varshney R, Dwarakanath B, Jain V. 2005. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells. Int J Radiat Biol. 81:397–408.
   PubMed Web of Science ®Google Scholar
• Wang C, Li X, Wang Y, Liu Z, Fu L, Hu L. 2013. Enhancement of radiation effect and increase of apoptosis in lung cancer cells by thio-glucose-bound gold nanoparticles at megavoltage radiation energies. J Nanopart Res. 15:1642.
   Web of Science ®Google Scholar
• Wang QW, Lu HL, Song CC, Liu H, Xu CG. 2005. Radiosensitivity of human colon cancer cell enhanced by immunoliposomal docetaxel. World J Gastroenterol. 11:4003–4007.
   PubMed Web of Science ®Google Scholar
• Xiao F, Zheng Y, Cloutier P, He Y, Hunting D, Sanche L. 2011. On the role of low-energy electrons in the radiosensitization of DNA by gold nanoparticles. Nanotechnology. 22:465.
   Web of Science ®Google Scholar
• Xu Y. 2008. Induction of genetic instability by gain-of-function p53 cancer mutants. Oncogene. 27:3501–3507.
   PubMed Web of Science ®Google Scholar
• Ye Q, Wang T-F, Peng Y-F, Xie J, Feng B, Qiu M-Y, Li LH, Lu AG, Liu BY, Zheng MH. 2010. Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease. Oncol Rep. 23:429–436.
   PubMed Web of Science ®Google Scholar